Obesity,insulin resistance and assisted conception

Abstract

Obesity and infertility are intrinsically linked, with both maternal and paternal obesity adversely affecting fecundity and assisted conception outcomes. The potential mechanisms linking obesity to altered gonadal function are not known but may speculatively include an altered adipokine milieu, but further research is required. Regardless of mechanisms, any reduction in fertility is not overcome by assisted conception, with maternal obesity associated with increased gonadotrophin requirements, lower oocyte yields, reduced fertilisation and impaired pregnancy rates. Furthermore in those who achieve pregnancy all maternal and perinatal risks are increased in conjunction with obesity, further reducing the probability of a healthy offspring. Optimisation of preconceptual weight irrespective of whether it is a spontaneous or assisted conception is essential to minimise these risks. Fortunately assisted conception provides us with a unique opportunity to engage with patients prior to achieving a pregnancy, and clinicians must exploit this ensuring that patients are fully informed as to the advantages of providing the best possible maternal environment and the positive impact it will have on their offspring. Br J Diabetes Vasc Dis 2009;9:23—266

Keywords

assisted conception obesity PCOS weight loss

Get full access to this article

View all access options for this article.

References

Kanagalingam MG , Forouhi NG , Greer IA , Sattar N. Changes in booking body mass index over a decade: retrospective analysis from a Glasgow Maternity Hospital. BJOG 2005;112:1431-3.

Ramlau-Hansen CH , Thulstrup AM , Nohr EA , Bonde JP , Sorensen TIA , Olsen J. Subfecundity in overweight and obese couples . Hum Reprod 2007;22:1634-7.

Hfea. A long term analysis of the Human Fertilisation and Embryology Authority Register data (1991-2006). London : Human Fertilisation and Embryology Authority, 2008

Shayeb AG , Bhattacharya S. Male obesity and reproductive potential. Br J Diabetes Vasc Dis 2009;9:7-12.

Matkovic V. , Ilich JZ , Skugor M. et al. Leptin is inversely related to age at menarche in human females . J Clin Endocrinol Metab 1997;82:3239-45.

Andreelli F. , Hanaire-Broutin H. , Laville M. , Tauber JP , Riou JP , Thivolet C. Normal reproductive function in leptin-deficient patients with lipoatropic diabetes. J Clin Endocrinol Metab 2000;85:715-9.

Budak E. , Fernández Sánchez M. , Bellver J. , Cerveró A. , Simón C. , Pellicer A. Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. Fertil Steril 2006;85:1563-81.

Sirotkin AV , Mlyncek M. , Kotwica J. , Makarevich AV , Florkovicova I. , Hetenyi L. Leptin directly controls secretory activity of human ovarian granulosa cells: possible inter-relationship with the IGF/IGFBP system. Horm Res 2005;64:198-202.

Sirotkin AV , Mlyncek M. , Makarevich AV , Florkovicova I. , Hetenyi L. Leptin affects proliferation-, apoptosis- and protein kinase A-related peptides in human ovarian granulosa cells. Physiol Res 2008;57:437-42.

10.

Gonzalez RR , Caballero-Campo P. , Jasper M. et al. Leptin and leptin receptor are expressed in the human endometrium and endometrial leptin secretion is regulated by the human blastocyst. J Clin Endocrinol Metab 2000;85:4883-8.

11.

Bellver J. , Rossal LP , Bosch E. et al. Obesity and the risk of spontaneous abortion after oocyte donation . Fertil Steril 2003;79:1136-40.

12.

Robker RL Evidence that obesity alters the quality of oocytes and embryos. Pathophysiology 2008;15:115-21.

13.

Matthaei S. , Stumvoll M. , Kellerer M. , Haring HU Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev 2000;21:585-618.

14.

Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800.

15.

Lord JM , Flight IH , Norman RJ Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev 2003;2:CD003053.

16.

Tang T. , Glanville J. , Hayden CJ , White D. , Barth JH , Balen AH Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod 2006;21:80-89.

17.

Harborne L. , Fleming R. , Lyall H. , Norman J. , Sattar N. Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet 2003;361:1894-901.

18.

Tang T. , Glanville J. , Orsi N. , Barth JH , Balen AH The use of metformin for women with PCOS undergoing IVF treatment . Hum Reprod 2006;21:1416-25.

19.

Kjotrod SB , von During V. , Carlsen SM Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study. Hum Reprod 2004;19:1315-22.

20.

Legro RS , Barnhart HX , Schlaff WD et al. Cooperative Multicenter Reproductive Medicine Network. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007;356:551-66.

21.

Ketel IJG , Stehouwer CDA , Serne EH et al. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance. J Clin Endocrinol Metab 2008;93:3365-72.

22.

Thessaloniki EA-SPCWG. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008;23:462-77.

23.

Sepilian V. , Nagamani M. Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance. J Clin Endocrinol Metab 2005;90:60-5.

24.

Minge CE , Bennett BD , Norman RJ , Robker RL Peroxisome proliferatoractivated receptor-γ agonist rosiglitazone reverses the adverse effects of diet-induced obesity on oocyte quality. Endocrinology 2008;149:2646-56.

25.

Chan Ly-S , Yeung JHK , Lau TK Placental transfer of rosiglitazone in the first trimester of human pregnancy . Fertil Steril 2005;83:955-8.

26.

Cho MC , Lee K. , Paik SG , Yoon DY Peroxisome proliferators-activated receptor (PPAR) modulators and metabolic disorders. PPAR Res 2008;2008:679137.

27.

Maheshwari A. , Stofberg L. , Bhattacharya S. Effect of overweight and obesity on assisted reproductive technology a systematic review. Hum Reprod Update 2007;13:433-44.

28.

Fedorcsak P. , Dale PO , Storeng R. et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 2004;19:2523-8.

29.

Nelson SM , Fleming RF The preconceptual contraception paradigm: obesity and infertility . Hum Reprod 2007;22:912-15.

30.

Cedergren MI , Kallen BA Maternal obesity and infant heart defects . Obes Res 2003;11:1065-71.

31.

Watkins ML , Rasmussen SA , Honein MA , Botto LD , Moore CA Maternal obesity and risk for birth defects. Pediatrics 2003;111:1152-8.

32.

Lashen H. , Fear K. , Sturdee DW Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod 2004;19:1644-6.

33.

Cnattingius S. , Bergstrom R. , Lipworth L. , Kramer MS Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 1998;338:147-52.

34.

Smith GCS , Shah I. , Pell JP , Crossley JA , Dobbie R. Maternal obesity in early pregnancy and risk of spontaneous and elective preterm deliveries: a retrospective cohort study . Am J Public Health 2007;97:157-62.

35.

Cedergren MI Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 2004;103:219-24.

36.

Tsagareli V. , Noakes M. , Norman RJ Effect of a very-low-calorie diet on in vitro fertilization outcomes. Fertil Steril 2006 ;86:227-9.

37.

Bloomfield FH , Oliver MH , Hawkins P. et al. A periconceptional nutritional origin for noninfectious preterm birth. Science 2003 ; 300:606.

38.

Balen AH , Anderson RA Impact of obesity on female reproductive health: British Fertility Society, Policy and Practice Guidelines. Hum Fertil (Camb) 2007;10:195-206.